PPMD's Blog – May 2016 Archive (3)

Sarepta Announces FDA Will Not Complete the Review of the Eteplirsen NDA By The PDUFA Date

The FDA has notified Sarepta that they are continuing their review of eteplirsen and will not be able to complete their work by the Prescription Drug User Fee Act (PDUFA) goal date of May 26, 2016.…

Continue

Added by PPMD on May 25, 2016 at 12:00pm — No Comments

PPMD Names Children’s Mercy Hospital in Kansas City, MO, Certified Duchenne Care Center

PPMD Awards Eleventh Clinic Certification as Part of Effort to Ensure People with Duchenne Receive Optimal Care

 

Children’s Mercy Hospital (Children’s Mercy) in Kansas City, Missouri, became the 11th clinic named a…

Continue

Added by PPMD on May 16, 2016 at 2:08pm — No Comments

Next Steps with Newborn Screening

For more than two years, PPMD has been leading a national effort to build a newborn screening infrastructure for Duchenne in the U.S.

Led by PPMD's Annie Kennedy, Michele Lloyd–Puryear, M.D., Ph.D., Newborn Screening Consultant for PPMD, and Jerry Mendell, MD of Nationwide Children's, the effort includes more than 50 of the worlds top newborn screening…

Continue

Added by PPMD on May 16, 2016 at 8:30am — No Comments

Monthly Archives

2018

2017

2016

2015

2014

2013

2012

2011

2010

Need help using this community site? Visit Ning's Help Page.

Members

Events

© 2019   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service